PATENT CLAIM ANALYSIS

Application Number: 16409026
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-11
Patent Classification: ["546", "118000"]

Abstract:
Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.

Claim (Index 24):
The compound of  claim 1 , or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein R 3  is C 3-8  cycloalkyl, optionally substituted with 1 or 2 substituents independently selected from COOH and OH.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 100.0
- Lexical Diversity: 1.3871
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15316534', '14446411', '13542153', '15772887', '15850170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8157772397393275
- 35 USC 102 Novelty (BERT): 0.5303129614658465
- Combined Prediction Score: 0.7872308119119794
- Mean Citation Score: 344.952562
- Max Citation Score: 368.0464
- Similarity Product: 303.51360607910163

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test